Danaher Corp. (NYSE:DHR) shares gapped up before the market opened on Wednesday . The stock had previously closed at $80.78, but opened at $80.88. Danaher Corp. shares last traded at $81.24, with a volume of 833,900 shares trading hands.

DHR has been the topic of a number of research analyst reports. Goldman Sachs Group Inc. raised their price objective on shares of Danaher Corp. to $98.00 in a research note on Wednesday, March 23rd. Sanford C. Bernstein lowered shares of Danaher Corp. from an “outperform” rating to a “market perform” rating and raised their price objective for the company from $104.00 to $105.00 in a research note on Monday, April 4th. Zacks Investment Research upgraded shares of Danaher Corp. from a “hold” rating to a “buy” rating and set a $104.00 price objective on the stock in a research note on Monday, April 11th. Deutsche Bank AG reiterated a “hold” rating and set a $83.00 price objective on shares of Danaher Corp. in a research note on Sunday, April 17th. Finally, Barclays PLC lowered their price objective on shares of Danaher Corp. from $104.00 to $99.00 and set an “overweight” rating on the stock in a research note on Monday, April 18th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and ten have assigned a buy rating to the stock. Danaher Corp. has an average rating of “Hold” and a consensus target price of $98.50.

The firm has a market cap of $56.05 billion and a price-to-earnings ratio of 16.13. The firm’s 50-day moving average price is $77.08 and its 200-day moving average price is $71.53.

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 29th. Investors of record on Friday, June 3rd will be given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 0.79%. The ex-dividend date of this dividend is Wednesday, June 1st.

In related news, EVP James A. Lico sold 58,954 shares of the firm’s stock in a transaction dated Wednesday, April 27th. The shares were sold at an average price of $96.93, for a total transaction of $5,714,411.22. Following the transaction, the executive vice president now directly owns 181,517 shares of the company’s stock, valued at $17,594,442.81. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, SVP Angela S. Lalor sold 8,392 shares of the firm’s stock in a transaction dated Thursday, May 12th. The stock was sold at an average price of $97.77, for a total transaction of $820,485.84. Following the transaction, the senior vice president now directly owns 48,110 shares in the company, valued at $4,703,714.70. The disclosure for this sale can be found here.

A number of institutional investors have added to or reduced their stakes in the company. Moors & Cabot Inc. raised its position in Danaher Corp. by 9.9% in the fourth quarter. Moors & Cabot Inc. now owns 11,788 shares of the company’s stock worth $1,099,000 after buying an additional 1,065 shares in the last quarter. Genesee Valley Trust Co. increased its stake in shares of Danaher Corp. by 39.7% in the fourth quarter. Genesee Valley Trust Co. now owns 11,978 shares of the company’s stock worth $1,113,000 after buying an additional 3,402 shares during the last quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC increased its stake in shares of Danaher Corp. by 4.0% in the fourth quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 12,035 shares of the company’s stock worth $1,118,000 after buying an additional 460 shares during the last quarter. Hemenway Trust Co LLC increased its stake in shares of Danaher Corp. by 174.9% in the fourth quarter. Hemenway Trust Co LLC now owns 12,646 shares of the company’s stock worth $1,175,000 after buying an additional 8,046 shares during the last quarter. Finally, Bronfman E.L. Rothschild L.P. purchased a new stake in shares of Danaher Corp. during the fourth quarter worth about $1,189,000.

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. It operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental, and Industrial Technologies. The Test & Measurement segment offers test, measurement and monitoring products.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.